<!DOCTYPE html>
<html>
<head>
	<title>Dr.Reddy's Laboratories</title>
</head>
<body>
<center><h1>Dr.Reddy's Laboratories pvt.ltd</h1></center>
<center><h3>~Good Health can't wait~</h3></center>
<center><pre><h4>Home || Businesses || ESG Goals || Awards || Career || Contact us</h4></pre></center>
<h3>About</h3>
<pre>
We serve customers around the world through our businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products.
In our branded businesses we focus on patient needs in the areas of gastro-enterology, cardiovascular, diabetology, oncology, pain management and dermatology.
We are actively developing a pipeline of novel small molecules in immuno-oncology.We are working on a pipeline of differentiated products that improve existing therapeutic agents.
We are also investing in emerging areas such as digital therapeutics, cell and gene therapies, among others.</pre>
<h3>Our Capabilities</h3>
<pre>
We leverage our research and development expertise, end-to-end manufacturing know-how and progressive digital technology to deliver on our promises to patients around the world.</pre>
<h3>Our Businesses</h3>
<pre>
-Branded Generics
-Generics
-Active Pharmaceutical Ingredients
</pre>
<h3>Our current ESG goals</h3>
<pre>
-Being committed to environmental stewardship
-Making our products accessible and affordable to patients
-Contributing to a fairer and more socially inclusive world
-Enhancing trust with our stakeholders
</pre>
</pre>
<h3>Business Partners</h3>
<pre>
Ensuring a continuous supply, remaining cost-competitive and guaranteeing highest quality are vital to provide affordable medicines to patients worldwide.
To achieve this, we work with business partners in various ways across the value chain. We emphasize fair, transparent and ethical practices and seek partners who share the same commitment towards compliance with laws, regulations, published standards and environmental practices.
</pre>
<h3>Accreditations and awards</h3>
<pre>
<b>.Gold Medal status by EcoVadis</b>
We have been awarded ‘Gold Medal’ status by EcoVadis, the global sustainability ratings agency, for its score of 72 out of 100 in its scorecard for 2023.
<b>.Dow Jones Sustainability Index</b>
We have become the first Indian pharma company to earn a place in the Standard & Poor Dow Jones Sustainability World Index (DJSI World) for 2023. Alongside our debut in DJSI World, we also retain our place in the Dow Jones Sustainability Index for Emerging Markets (DJSI EM) for the 8th year in a row.
Asia-Pacific Climate Leader 2024 by the Financial Times (London)
For the second year in a row, The Financial Times (London) has named us an ‘Asia-Pacific Climate Leader' in its 2024 list. The annual study is compiled by Financial Times and Statista. Asia-Pacific Climate Leaders 2024 is a list of 350 Asia-Pacific companies that have achieved the greatest reduction in their core emissions intensity over the 5-year period between 2017 and 2022.
</pre>
<h3>Careers</h3>
<pre>
<b>Life at Dr.Reddy’s</b>
Talented people have played a major role in powering and defining the growth of Dr. Reddy’s over the past four-odd decades. They have been supported by an enabling environment that buoys individual ability while fostering teamwork and shared success. We believe that when people with diverse skills are bound together by a common purpose and value system, they can make magic.
</pre>
<h3>Contact us</h3>
<pre>
<b>call:- +91 00000 00000
email:- drreddys@gmail.com</b>
</pre>
</body>
</html>